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Abstract
Research has shown that physical activity is essential in the prevention and treatment of
chronic diseases like cardiovascular disease (CVD). Smart wearables (e.g., smart-
watches) are increasingly used to foster and monitor human behaviour, including physical
activity. However, despite this increased usage, little evidence is available on the effects
of smart wearables in behaviour change. The little research which is available typically
focuses on the behaviour of healthy individuals rather than patients. In this study, we
investigate the effects of using smart wearables by patients undergoing cardiac rehabilita-
tion. A field experiment involving 29 patients was designed and participants were either
assigned to the study group (N = 13 patients who finished the study and used a self-track-
ing device) or the control group (N = 16 patients who finished the study and did not use a
device). For both groups data about physiological performance during cardiac stress test
was collected at the beginning (baseline), in the middle (in week 6, at the end of the reha-
bilitation in the organized rehabilitation setting), and at the end of the study (after 12
weeks, at the end of the rehabilitation, including the organized rehabilitation plus another
6 weeks of self-organized rehabilitation). Comparing the physiological performance of
both groups, the data showed significant differences. The participants in the study group
not only maintained the same performance level as during the midterm examination in
week 6, they improved performance even further during the six weeks that followed. The
results presented in this paper provide evidence for positive effects of digital self-tracking
by patients undergoing cardiac rehabilitation on performance of the cardiovascular sys-
tem. In this way, our study provides novel insight about the effects of the use of smart
wearables by CVD patients. Our findings have implications for the design of self-manage-
ment approaches in a patient rehabilitation setting. In essence, the use of smart
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wearables can prolong the success of the rehabilitation outside of the organized rehabili-
tation setting.
Introduction
A healthy lifestyle, which is a key determinant in the prevention and treatment of chronic dis-
eases, involves regular physical activity [1]. Evidence indicates that physical activity is a major
determinant of chronic diseases, in particular of cardiovascular disease (CVD) [2–6]. Less
activity than 5,000 steps per day, for example, is associated with unfavourable indicators of car-
diometabolic risk [7]. Furthermore, sedentary behaviour is known to influence the risk for
chronic conditions such as CVD [8]. Today’s living environments (e.g. transport facilities,
workplace designs, and electronic communication), however, foster diminished physical activ-
ity. Thus, if compared to the past, the way modern humans move and sit in everyday life has
changed fundamentally in the last few decades [6,8].
Concurrently, in recent years there has been an increasing interest in self-tracking through
computer technology to improve health and medical conditions. Specifically, the increased
ability of individuals to perform self-monitoring through smartphone apps and web services
contributed to this development. In research areas such as obesity studies (self-tracking of
weight loss), psychology (collecting mood data), or diabetes care, research has already estab-
lished positive effects [9,10]. However, current research on the effects of smart wearables (e.g.,
activity trackers) has primarily focused on healthy individuals rather than patients.
In outpatient cardiac rehabilitation, besides scheduled physical exercise sessions in a reha-
bilitation environment, leisure time physical activity (LTPA) has been shown to positively
affect health conditions [11–13]. Thus, to make changes towards a healthy lifestyle, patients
should increase their activities and reduce time spent in a seated position. Giving them the
possibility to digitally track their behaviour (e.g., daily steps) may increase awareness of LTPA
including sedentary behaviour, and this, in turn, may lead to more LTPA, thereby improving
the cardiovascular health status [5,14,15].
Consumer wearable devices for activity tracking promise an enhancement of recovery in
cardiac and pulmonary rehabilitation [16]. Specifically, such devices enable the monitoring
of activities during the recovery process in real life (e.g., at home or in community settings),
allow medical professionals to collect data from individuals (e.g., to monitor whether
patients are following their recommendations during rehabilitation [17]), and provide a
new way to determine improvement or deterioration of health [18–20]. Such devices also
provide support to outpatient cardiac rehabilitation services and offer a cost-effective and
feasible alternative to hospital-based rehabilitation programmes and services [21,22]. Thus,
use of consumer wearable devices may improve the allocation of healthcare resources and
increase efficiency and quality of healthcare systems [23]. Altogether, health tracking
devices can be used to address the behavioural risk factors of CVD by encouraging an
increase in LTPA [24,25], a fact that holds particularly true for the prevention of coronary
heart disease [26].
However, current studies on physical activity are mostly based on questionnaires and sub-
jective self-reporting by healthy individuals, and tend to focus on specific activities and less on
routine daily activities of light intensity [1,4]. Also, the usage of activity monitors to measure
physical activity in clinical contexts is limited [27]. Napolitano et al. write that an “objective
measurement of physical activity behaviour is a critical missing component in physical activity
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clinical trials” (p. 521 of [28]). Although the use of consumer wearable devices is promising for
healthcare, it is still in the early stages of development and has rarely been approved for medi-
cal use by real patients [29]. Also, there are only a few studies providing insight about the use
of wristband activity trackers for monitoring and improving health outcomes among the
elderly [30]. Thus, a research gap exists on the effects of the use of consumer wearable devices
by chronic disease patients for self-management on health outcomes [16].
To the best of our knowledge, no controlled peer-reviewed studies that investigate the mon-
itoring of patients’ LTPA by wearing an activity tracker during and after outpatient cardiac
rehabilitation have been published. It follows that insights about a tracker’s role and its poten-
tial effects on the development of patients’ physical activity and health is limited. Wrist-worn
activity trackers given to patients should help them to record their LTPA and support them in
monitoring these activities. This should lead to patients having a greater awareness of their
own physical activity behaviour. Therefore, in the present study we investigate the following
hypothesis:
Patients undergoing cardiac rehabilitation who objectively record leisure time physical activity
by using a digital activity tracker show higher improvement of the cardiovascular system after 12
weeks than patients undergoing cardiac rehabilitation who do not objectively record leisure time
physical activity by using a digital activity tracker.
The remainder of this paper is structured as follows: in the first section, we provide back-
ground knowledge on physical activity and health, including a more specific discussion of
CVD and physical activity during rehabilitation. Afterwards, we review literature on smart
wearables and their application in health monitoring. Both sections constitute the conceptual
basis of the present study and provide insight into the rationale underlying the hypothesis that
we tested in a field study. What follows then is a description of our research approach, includ-
ing a description of our study population and the methods. Afterwards, we present our results,
grouped into the descriptive statistics of activity data and the hypothesis testing. We close this
paper with a discussion of the findings, including an outline of the study’s limitation and a
concluding comment.
Physical activity and health
The intensity level of physical activity is commonly referred to as light, moderate, and vigorous
[31]. On an absolute scale, moderate intensity refers to activity that is performed 3.0–5.9 times
and vigorous intensity 6.0 or more times the intensity of rest [3], depending on people’s skill
level and body composition [4]. The most recent evidence-based recommendations for adults
(aged 18 to 65) on physical activity and public health call for at least 30 minutes of moderate-
intensity physical activity five days a week, 20 minutes of vigorous-intensity physical activity
three days a week or an equivalent combination of moderate to vigorous physical activity
(MVPA). Exceeding the minimum recommended amounts has been shown to reduce the risk
for chronic diseases [1,4]. If adults are unable to follow up recommendations due to health
conditions, they should, nevertheless, be as physically active as possible. They can still benefit
from amounts below the recommended threshold, particularly if they are habitually inactive
[6]. However, although findings show the beneficial effects of MVPA [15], these activities
decline with increasing age [32] and especially older adults tend to spend the majority of their
time engaged in sedentary or light physical activity. Reducing total sedentary time and replac-
ing it with light physical activity or short periods of standing, has beneficial effects on health,
even in physically active adults [1,12]. Counted steps explain the majority of the daily variabil-
ity in time spent on MVPA [7]. Reaching a daily step-count of about 7,000 steps or more is
classified as being physically active [1].
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CVD is the single largest cause of death worldwide [33]. Although rates of CVD death have
declined, still almost a third of all deaths are attributed to CVD (30.8%) [2]. Physical activity
not only plays a decisive role in staying healthy and preventing chronic diseases, but is also a
key factor in the treatment of diseases, particularly CVD [11,34]. Cardiac rehabilitation
involves a variety of therapies by an interdisciplinary team and consists of exercises, education,
and psychological support. Its general objectives are to regain fitness and health, thereby
enhancing quality of life and reducing the likelihood of dying from heart disease [35–37] or to
“prevent subsequent coronary events, subsequent hospitalization, and death from cardiac
causes through a program of prescribed exercise and interventions designed to modify coro-
nary risk factors” (p. 892 of [38]). Generally, it “is indicated for patients who have received a
diagnosis of acute myocardial infarction, those who have undergone coronary revasculariza-
tion, and those with chronic stable angina” [38].
In Austria, the country in which the empirical study reported in this paper was conducted,
the follow-up treatment after early mobilization or a hospital stay after an acute cardiac event
is referred to as phase II rehabilitation with a duration of 6 weeks. It is either hospital/centre-
based or outpatient/home-based, both producing similar favourable outcomes for patients
who adhere to corresponding guidelines [39,40]. During phase II rehabilitation endurance and
resistance training takes place three times a week (up to 50 minutes) under supervision of a
rehabilitation physician and a sports scientist (exercise physiologist). All programmes follow
the Austrian Guidelines of Outpatient Cardiac Rehabilitation, which have been endorsed by
the Austrian Society of Cardiology [41,42]. Patients’ exercise capacity usually improves
through rehabilitation by 20 watts (W; watt as in the unit of power), and rehabilitation leads to
improvement in cardiovascular risk factors (e.g., systolic blood pressure, BMI, or psycho-car-
diac parameters) [43]. Moreover, the average MVPA increases significantly during a 12-week
home-based cardiac rehabilitation programme [37].
Smart wearables and monitoring in healthcare
Consumer wearable devices and activity trackers. Wearable devices, which can be
defined as “mobile electronic devices that can be unobtrusively embedded in the user’s outfit”
(p. 232 of [44]), are able to recognize the user’s specific situations due to context sensitivity
[44]. Their main purpose is to collect and analyse data on the individual’s state and behaviour
[45]. In recent years, wearable devices for tracking purposes have developed at a stunning pace
due to cheap computer storage and rich user interfaces [46,47].
Activity trackers support people trying to improve their health, physical performance, or
overall wellness by monitoring their activities and activity-related metrics (e.g., kcals burned)
in their everyday lives [48]. They are mostly designed as bracelets with a graphic display or
vibration for user-device interaction [49]. In general, studies investigating activity trackers
show high measurement validity and inter-device reliability of step-counts, but lower validity
for energy expenditure and sleep assessment [48]. Although most wearable devices are accu-
rate for tracking purposes, in some cases a more than 20% deviation to actual step-counts was
found [50]. Causes of poor reliability can be related to the inaccuracy of sensors, the failure of
software algorithms or the users themselves who try to intentionally cheat the recognition sys-
tem (e.g., by shaking the device) to appear more active [17].
Wearables and healthcare. Wearables enable patients to take an active role in their
healthcare and prevention of diseases by giving feedback on the relation between physiological
parameters and activities [45]. While tracking ourselves we are collecting detailed data about
our body, which can be easily kept for records [51]. Therefore, wearable technology is becom-
ing integrated in our everyday lives [52] and “[t]he line between consumer health wearables
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and medical devices begins to blur” (p. 1 of [29]). Generated data gives individuals access to
personal analytics and could help in managing medical risk factors. Wearables could monitor
patients’ progress in an easy and comfortable way and “could provide a platform for at-home
management of long-term chronic conditions” (p. 3 of [29]). New technologies and data about
behaviour enable doctors to look after patients during their LTPA, regardless of geographical
distances or boundaries [53]. Monitoring someone’s physical activity can increase overall
activity significantly [54]. It has been shown that outpatient adults using pedometers signifi-
cantly increased their own step-count or activity per day [55]. In general, the technological
development of self-monitoring systems has been advancing faster than the rate at which
human society is able to understand its consequences. The generated data gives a powerful and
intimate insight into ourselves, including both human physiology and behaviour [56].
Measuring methods. Basically, methods for measuring physical activity are divided into
two groups: self-reports and objective measures (e.g., motion sensors such as accelerometers)
[6,11]. Self-reports like questionnaires, have been the most commonly used method for assess-
ing physical activity. However, self-reports constitute subjective assessment, and hence a num-
ber of measurement biases may occur, such as memory distortion or social desirability bias
[14,28,57,58]. Discrepancies between self-report measures of physical activity and those
directly measured are reported [59]. It follows that questionnaires for assessments of physical
activity are limited regarding reliability and validity [60,61].
While adults typically subjectively overestimate their physical activity or its intensity in self-
reports, accelerometers provide approximately true values, [14,57]. Moreover, older adults face
difficulties in recalling the intensity, frequency, and duration of their activity [12]. Therefore,
at present, accelerometers seem to be one of the most reliable and relatively affordable alterna-
tives to gather detailed information about physical activity and its intensity levels. They are
defined as “devices that measure body movements in terms of acceleration, which can then be
used to estimate the intensity of PA [physical activity] over time” (p. 490 of [62]). Compared to
pedometers, which only measure the presence of an actual movement, accelerometers measure
the magnitude of force generated by movement, which is referred to as acceleration. Activity
trackers also use this to estimate energy expenditure (e.g., in the form of Kcal burned) [27].
Technically, the generated data is first recorded by an internal memory and then trans-
ferred to computers or Internet servers. The total daily activity, the time spent at different
intensity levels, changes in activity patterns, and the characterisation of sedentary behaviour
are widely used measures. To obtain most reliable and valid results from a clinical research
perspective, the use of a triaxial accelerometer worn on a participant’s non-dominant wrist is
recommended. To capture both weekdays and weekends the minimum period of wear should
be 7 days. Although, obviously, most detailed outcomes tend to be achieved by wearing activity
trackers 24 hours a day, a minimum of 12 hours’ wear time per day generally results in accu-
rate estimates of daily physical activity [27].
Basically, the perception about the feasibility and utility of wristband activity trackers is pos-
itive among adults aged 60 or older [30]. The acceptability of apps based on motivational
frames of behavioural science theory which should help to increase MVPA and reduce seden-
tary time is also confirmed for adults aged 45 or older who were not familiar with the technol-
ogy and insufficiently physically active [63]. Furthermore, devices attached to the wrist seem
to be the most readily accepted manner for monitoring physical activity by older adults [64].
Behaviour change. Although we know that lifestyle is essential for the prevention and
treatment of chronic diseases like CVD, it is challenging for people to change their lifestyle.
Reasons for this may be a person’s socio-economic status (e.g., low educational level), social
isolation (e.g., living alone), stress, negative emotions (e.g., depression), or that recommenda-
tions for physical activity could be misunderstood [6].
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Using wearables for healthcare purposes has psychological effects on the patient [18] and
behaviour or cognitive behaviour change can support the assistance of patients [65]. Com-
puter-based solutions can effectively cause behavioural change to help prevent chronic diseases
such as CVD [66]. Activity trackers may act as an interactive behaviour change tool as they can
provide immediate feedback to the user. They show the daily progress of physical activity and
enable sharing and comparing data with other users, both of which could be a motivation to
increase overall physical activity. Activity trackers also use a variety of potentially effective
behaviour change techniques known from typical clinical interventions. They include, for
example, goal-setting, showing differences between current and goal behaviour, visual cues,
self-monitoring, or motivating feedback [67]. Against this background, activity trackers and
their applications seem to hold significant potential for use in rehabilitation settings. In gen-
eral, mobile technology interventions in healthcare are effective and already show benefits in
different domains, such as increased physical activity in the short term and improved cardio-
vascular risk profiles [68].
Field experiment
A field experiment with patients undergoing rehabilitation was performed at the outpatient
cardiac rehabilitation centre Cardiomed in Linz, Austria in cooperation with the School of
Management of the University of Applied Sciences Upper Austria and Dublin City University.
The study was approved by the responsible Management Board of the University of Applied
Sciences Upper Austria and the Dublin City University Research Ethics Committee (REC Ref-
erence: DCUREC/2016/011). Both confirmed that the study was conducted under mutual
consideration of scientific and ethical aspects. (Written) Informed consent was given by all
participants.
Method
Randomly selected male patients who attended outpatient cardiac rehabilitation phase II (fol-
low-up treatment after early mobilization or hospital stay after an acute cardiac event) were
divided into two groups by a standard software-based random sample generator. One group of
patients, referred to as ‘study group’ (N = 19), was provided with activity trackers for a dura-
tion of 12 weeks and asked to perform a supplementary examination at the end of their obser-
vation period. Another group of patients, referred to as ‘control group’ (N = 17), was asked to
undergo a supplementary examination 12 weeks after commencement of their rehabilitation
without any further intervention (no activity tracking). To compare improvement of different
parameters (e.g., performance of cardiovascular system) between the study and control group,
results based on three different examinations (t1, t2, t3) were analysed.
The total duration of the field experiment was 29 weeks over a period of 8 calendar months
(from October 2015 to May 2016). At the outpatient cardiac rehabilitation centre usually a
group consisting of 12 patients (mainly men) starts rehabilitation every two weeks. Partici-
pants were recruited from these routine rehabilitation groups on the day of their baseline
examination. The groups for the study were designed to avoid an overlap of study and control
group participants in the same routine rehabilitation group to ensure that participants of dif-
ferent groups could not influence each other. The baseline examination took place at the
beginning (in week 1) and the midterm examination at the end (in week 6) of the rehabilita-
tion programme. A supplementary examination, which was only performed as a consequence
of this field experiment, took place after 12 weeks (in week 13). The observation period (period
for tracking and monitoring of physical activity) was therefore 12 weeks per participant.
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Our step-by-step laboratory protocol is available in protocols.io: https://dx.doi.org/10.
17504/protocols.io.jhacj2e. [PROTOCOL DOI]
Participants. Physical activity levels may vary depending on gender [37]. Further, patients
at the outpatient cardiac rehabilitation centre are predominantly male. To avoid the risk of
skewed results influenced by gender differences, and to enable recruitment of an adequate
number of participants within a limited time frame, only male participants were included in
the study. Additional inclusion criteria were that participants were aged 40–80 and had been
diagnosed with CVD (ST-elevation myocardial infarction (STEMI), non-ST-elevation myocar-
dial infarction (NSTEMI), percutaneous coronary intervention (PCI) or coronary revasculari-
sation) within the previous 3 months. Eligible participants had been clinically stable for at least
two weeks before the start of the study and were able to participate in the rehabilitation pro-
gramme, including the performance of the recommended physical activity. They had to give
informed consent, and had a personal computer with access to the Internet at home. Patients
were excluded if they were suffering from Parkinson’s disease or other medical conditions
such as uncontrolled atrial or ventricular dysrhythmias, or if they were unable to participate in
MVPA due to physical limitations.
All participants received detailed information in the form of an introductory face-to-face
conversation (duration approximately 30 minutes) conducted by a subset of the authors of
this paper; the conversation was about the purpose and procedure of the study, benefits and
risks to the participants, effects on medication and lifestyle, expected symptoms, side effects or
injuries, information about premature termination of participation, use of data and results,
costs of participation, reimbursement of costs and remuneration, and contact details for fur-
ther inquiries. Additionally, all information was provided to participants in written form in
easily understandable language. The consent form was signed by the patient and the responsi-
ble author only after all patient questions were answered satisfactorily; hence the patient
completely understood the way in which the study was to be conducted, was aware of his rights
as a participant, was willing to consent to participation and confirmed that he had had enough
time to think about whether he wished to participate in the study or not.
All participants attended routine cardiac rehabilitation during the first six weeks of the
study with heart rate controlled moderate to vigorous physical activity, nutritional education,
and psychological support. Exercises were partly supervised at the rehabilitation centre and
partly conducted at home. The recommendation and duration of the patients’ medication
were not affected by this field experiment and therefore remained unchanged. Further, there
was no additional medication for reasons related to this study. After the examination six weeks
from start participants got medical recommendations for their future lifestyle (including phys-
ical activity). For the following six weeks (until the supplementary examination in week 13)
the study group participants continued to wear the activity tracker. Thus, for participants in
the control group, as in their first six weeks, there was no intervention until the supplementary
examination.
All participants were Austrian citizens. Nineteen male cardiac patients undergoing rehabili-
tation were recruited to participate in the study group. Six of them were unable to complete
rehabilitation for medical reasons (not related to the field experiment) at different times
throughout the study and had to terminate their participation. Therefore, 13 participants of
this group ultimately finished the study and attended all examinations. Seventeen male
patients were recruited to participate in the control group, one of whom was unable to com-
plete rehabilitation for medical reasons (unrelated to the field experiment). Therefore, 16 par-
ticipants of this group ultimately finished the study and attended all examinations. The total
number of participants recruited for both groups combined was 36; the total number of partic-
ipants finishing the study was 29. The mean age on the day of rehabilitation commencement
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(initial examination) was 61.69 (SD = 8.62; max = 75; min = 44) for the study group and 63.75
(SD = 10.32; max = 77; min = 44) for the control group. There was no statistically significant
difference in age between the study and control groups (p = .584).
Examinations. At the beginning (t1), in week 6 (t2), and after 12 weeks (t3) an examina-
tion of the participants’ physiological performance (including lactate measurement) took place
at the rehabilitation centre. All measures were performed by a medical doctor or a trained
exercise physiologist (under supervision of a medical doctor, to deal with any emergencies). A
graded exercise test (cardiac stress test) was conducted on an electronically braked cycle
ergometer. The exercise test enables the determination of a participant’s maximum exercise
capacity [69]. It is a standard diagnostic process in cardiology and follows the latest Practice
Guidelines for Exercise Testing [70] which provide recommendations about the procedure of
testing, the valuation of measured parameters and possible influences. Furthermore, they give
an overview of interruption and termination criteria. In our study, individual ramp protocols
were used according to the latest national guidelines [42,70] and international recommenda-
tions [69,71,72]. To ensure comparability of measures of t1, t2 and t3, these were kept identical
for all participants during the different examinations. Heart rate was monitored continuously
by a conventional 12 lead ECG with ten electrodes. Blood pressure was measured manually
with a standard medical measuring device. Participants performed maximum capacity exercise
testing until exhaustion or until individual ECG termination criteria were reached. In general,
we chose testing protocols lasting 8–12 minutes to the peak of exercise depending on the par-
ticipant’s physical status and capacity [70,71]. For the test, after an initial warm-up phase with
unloaded pedalling, the work rate during progressive uninterrupted exercise is regularly
increased after an adequate time interval in each level until the participant’s maximum work
rate (power given in W) is reached [69,71]. Therefore, our values and parameters used for
comparison of the participants’ physiological performance between examination t1, t2 and t3
and between the study and the control groups were the maximum power given in W achieved
by the participants during the cardiac stress test and their calculated relative performance as a
percentage (representing their actual performance during the cardiac stress test in relation to
their individual target values) [70].
Monitoring physical activity. The tracking and monitoring of study group participants’
leisure time activity was performed using the Polar Loop activity tracker which is a common
consumer smart wearable device. It is a bracelet-shaped, wrist-worn 3D accelerometer (triaxial
accelerometer) with a storage capacity of at least 7 days. This device only has basic features and
allows for easy navigation through the display via a single button.
Activity trackers were distributed to participants (free of charge) on the day of t1 and
returned on the day of t3. In order to synchronize data, devices had to be connected to a USB
port of a computer, where data was visualised. Participants were asked to wear the device on
their non-dominant wrist, if possible, 24 hours a day and seven days a week, to regularly
charge the (rechargeable) battery via computer (USB) or charging unit, and to regularly syn-
chronize the automatically collected activity data by using the provided software. Important
information about display views, features and functions, memory capacity, charging and
operating time, communication and technical specifications of the device, as well as system
requirements for the software and web service, was provided to the participants during the
introductory conversation. Furthermore, and to ensure that the device was comfortable to
wear, the bracelet size was individually customised to the wrist size of all participants. Addi-
tionally, all participants received a copy of the user manual.
The device is based on non-invasive sensors and can be classified as a mobile, on-body sys-
tem. Basically, it is a standalone system in which the collection (embedded sensors), analysis
(locally), and visualisation (on display) of data is done by the device itself. Because of the
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limited storage capacity of the device, data needs to be synchronised with a computer about
once a week to enable ongoing tracking. The switch between various modes (display views) is
performed via a single touch button. A numeric and graphic display consisting of 85 LED
lights in a 5 x 17 matrix gives feedback in the form of numbers and visualisations. All features
of the device are based on acceleration measurement. Therefore, the acceleration signal counts
and filters body movement, which is then classified into different intensity levels. The model
uses intensity levels (and thresholds) based on scientifically approved recommendations
[1,3,4]: non-wear (device not worn), sleep/rest (lying down), sitting (including other passive
behaviour), low intensity activity (light), medium intensity activity (moderate), and high inten-
sity activity (vigorous). Based on the different intensity levels and body parameters like age,
gender, or weight, values are further transferred into step-counts and energy expenditure in
the form of burned kilocalories (kcal). Feedback about daily activity is given textually (steps,
kcal) and via progress bar shown on the display of the device. After one hour of sedentary
behaviour a so-called ‘inactivity alert’ reminds the user to break up sitting time by showing the
text “It’s time to move” [73].
Data was automatically generated by participants while wearing the activity tracker. For
synchronizing data with a computer, participants had to download and install the free software
Polar FlowSync on their own PC or laptop. As some of the elderly people were not quite famil-
iar with this kind of process, it was explained to them in detail. Additionally, they received a
copy of an installation guide with step-by-step instructions (including screenshots) created by
the authors. Once the installation was completed and the device connected to the computer
via Polar’s custom USB cable the Polar Flow web service opened automatically in the default
browser. Nineteen e-mail addresses (Gmail accounts) and Polar accounts (necessary for using
the free web service) were prepared by the authors in advance. Activity trackers were set up,
updated to the latest software version, and connected to a Polar account. The study reference
number (which was also used as the name for the participants’ Polar Account), date of birth,
gender, weight, and height of every participant were also added to the accounts in advance.
Additionally, the privacy preferences of the web service were set to the most private level. Par-
ticipants received personal login data to access a pre-set account immediately after they had
agreed to participate in the study. Accounts were connected to a special coaching account held
by the authors. This enabled the authors to precisely monitor all synchronised activity data of
participants. Participants were informed that only the authors and medical staff at the rehabili-
tation centre have access to their activity data and that all personal information such as full
name and date of birth is subject to medical confidentiality. For statistical purposes and analy-
sis all data was anonymised to the study reference number so that it could not be traced to an
individual based on published results of the study.
Participants were advised to try to raise their awareness about their own physical
activity behaviour, to set realistic and achievable personal goals (such as total daily steps,
less overall time spent sitting, or just being more active than the day before) and not to
focus too much on the goals suggested by the activity tracker itself, which are generally
based on recommendations for healthy individuals rather than cardiovascular patients
(goals could not be customised according to individual characteristics of the patients’ dis-
ease or diagnosis).
Every three days the authors checked whether participants were synchronising their
activity data regularly. If anyone’s data was missing for more than five days, participants
were contacted (personally, by phone, or per e-mail), received a reminder to synchronise
data, or were asked whether there were any problems (e.g., with synchronisation or use of
the device).
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Results
All statistical analyses were performed with IBM SPSS Statistics version 20. The data behind
visualizations in this section are available in S1 and S2 Data.
Descriptive statistics of activity data
Over a total period of five calendar months (18 calendar weeks) activity data was collected
from participants of the study group. Only valid days with at least twelve hours of wear time
per day were used for data analysis. For statistical analysis, only valid days of participants who
finished the study and attended all examinations were used. In total, 1,059 valid days were
tracked by 13 participants with a mean number of 81.46 days per participant (SD = 5.33;
max = 86; min = 65). Only weeks with a total of seven valid days were declared as valid weeks.
In total, 163 weeks (including weeks 1 and 12) were tracked, of which 141 weeks were declared
as valid. The mean number of valid weeks was 10.85 weeks per participant (SD = 1.70;
max = 12; min = 6).
Activity data in this study was collected as number of steps, kcal burned, sedentary behav-
iour, total activity time (light + moderate + vigorous intensity) and physical activity of light
intensity in hours (h), and MVPA in min. To develop better insight into an actual activity pro-
file of CVD patients some results are presented as line charts in this article.
The participants’ average number of weekly steps (Fig 1) increases in the middle of the first
and second half of the study, fluctuates somewhat in between, and reaches its peak in week 9.
Compared to the beginning of rehabilitation (in week 2) the weekly number of steps increases
by almost 21,300 (+31.59%). Participants’ average of weekly burned kcal (Fig 2) increases
almost steadily over the first five weeks and then fluctuates after the end of the routine rehabili-
tation programme in week 6. The difference between week 2 and the peak in week 11 is 1,509
kcals (+8.57%). According to the regression lines, both steps and overall energy consumption
climbed steadily over the entire observation period.
Fig 3 shows participants’ average time of sedentary behaviour in h. It increases somewhat
from weeks 2 to 3, time edges up again to its peak in week 4 and then decreases until week 7.
After that it fluctuates slightly but stays nearly steady through week 11. At the end of the entire
Fig 1. Development of average weekly steps from weeks 2 to 11 (N = 13, study group).
https://doi.org/10.1371/journal.pone.0186261.g001
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period from weeks 2 to 11 participants spend almost 6 h less sitting compared to the beginning
(-9.09%).
Fig 4 shows participants’ weekly average total activity time (light, moderate, and vigorous
intensity combined) and time of light activity in h separately. After increasing from weeks 2 to
3, total activity time edges down again until week 5. Afterwards, it rises by 7.2 h (17.65%) from
40.8 up to 48.0 h in week 10. Time of light activity increases from weeks 2 to 3, decreases until
week 5 and then climbs again until week 7. Afterwards it stays almost flat for 2 weeks and then
reaches a peak in week 10. Regression lines show a steady climb of total activity time through-
out the study and an overall improvement of activity of light intensity by almost 6 hours
(+21.21%) from about 34 h in week 2 to almost 40 h at the end of the observation period.
Fig 5 shows participants’ weekly average time of MVPA in minutes, which has a peak in
both the first and second period. There is an increase of 160 min (+35.55%) between the lowest
Fig 2. Development of average weekly burned kcals from weeks 2 to 11 (N = 13, study group).
https://doi.org/10.1371/journal.pone.0186261.g002
Fig 3. Development of average weekly sedentary behaviour in h from weeks 2 to 11 (N = 13, study
group).
https://doi.org/10.1371/journal.pone.0186261.g003
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point in week 2 (450 min) and the peak in week 9 (610 min). Overall, the average increase
according to the regression line is about 18% or 80 min.
Hypothesis testing
For data analysis, the baseline examination is referred to as t1, the midterm examination after
6 weeks as t2, and the examination after 12 weeks as t3. To determine whether there is a differ-
ence between the study and control groups in physiological performance, at t1 their mean
maximum power given in W and mean relative performance as a percentage was calculated.
There is no statistically significant difference between the groups in baseline maximum power
(study group/control group: M = 165.462; SD = 51.164/M = 160.500; SD = 42.991; p = .779)
and relative performance (M = 98.923; SD = 28.713/M = 96.375; SD = 18.822; p = .776) at t1.
Maximum power and relative performance are then analysed by using a 2 (between-subjects
Fig 4. Development of average weekly total and light activity time in h from weeks 2 to 11 (N = 13, study
group).
https://doi.org/10.1371/journal.pone.0186261.g004
Fig 5. Development of average weekly MVPA in min from weeks 2 to 11 (N = 13, study group).
https://doi.org/10.1371/journal.pone.0186261.g005
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factor = intervention type: being a member of either the study group or the control group) x 3
(t1/t2/t3) repeated measures ANOVA to find out if maximum power or relative performance
differ depending on the intervention type and time of measurement. The analysis revealed a
significant main effect of time for maximum power (F(2,27) = 34.969; p = .000; partial η2 = .564)
and relative performance (F(2,27) = 23.878; p = .000; partial η2 = .469). The focus of the results
especially is on the different development in maximum power between t2 (study group/control
group: M = 185.385; SD = 55.206/M = 186.063; SD = 51.604) and t3 (study group/control
group: M = 192.077; SD = 53.877/M = 169.000; SD = 44.077) and relative performance
between t2 (study group/control group: M = 110.385; SD = 30.129/M = 111.813; SD = 23.092)
and t3 (study group/control group: M = 118.385; SD = 27.705/M = 101.125; SD = 21.841) (see
Fig 6). This means an improvement in maximum power of 6.69 W (+3.61%) for the study
group and a deterioration of 17.06 W (-9.17%) for the control group or an improvement in rel-
ative performance of 7.99% (+7.24%) for the study group and a deterioration of 10.78 (-9.64%)
for the control group. Considering the entire observation period (t3-t1), the study group
improves maximum power by an average of 26.62 W (+16.09%), the control group by an aver-
age of 8.50 W (+5.30%), and the study group improves relative performance by an average of
19.49% (+19.72%), the control group by an average of 4.71% (+4.90%).
Maximum power and relative performance are relevant and most common when compar-
ing indicators for improvement of the cardiovascular system. Indeed, there are significant dif-
ferences between the study and control group according to these parameters considering the
entire observation period and, in particular, between t2 and t3. Therefore, the hypothesis is
accepted.
Discussion
A strong relationship between physical activity and health has been reported in the literature.
Physical activity is essential in the prevention and treatment of chronic diseases like CVD. Fur-
ther, there are scientific recommendations for minimum activity levels. They show which
behaviour influences the risk for chronic diseases such as CVD (e.g., [1,4,6]. Prior studies have
Fig 6. Changes in mean maximum power given in watts (left chart) and relative performance as a percentage (right chart) of
study and control group at t1, t2 and t3 (examinations). Error bars represent the standard error of mean (SEM).
https://doi.org/10.1371/journal.pone.0186261.g006
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noted the potential of smart wearables for increasing physical activity or changing behaviour
towards a healthier lifestyle (e.g., [16,24,25,30]). However, no scientific study, to the best of our
knowledge, is available which investigates the relationship between digital consumer wearables
and health outcomes during rehabilitation in CVD patients. In addition, little insight is avail-
able on the effects of smart wearables, such as activity trackers, on behaviour change. As we
know that LTPA is a factor of success in cardiac rehabilitation, the present study investigated
patients who monitored their own activities and made decisive changes in activity and seden-
tary behaviour. It was designed to determine the effects of wearing activity tracking devices on
health outcomes. Therefore, the main question in this research was whether the use of digital
self-tracking for monitoring LTPA by CVD patients undergoing cardiac rehabilitation can
lead to an improvement of performance of the cardiovascular system. Further, the study aimed
to investigate physical activity in CVD patients and how physical activity develops throughout
rehabilitation and afterwards. It was hypothesised that patients who objectively record their
LTPA by using digital activity trackers show greater improvement of cardiovascular system
parameters after 12 weeks, as compared to a control group without any digital activity
tracking.
Over a total time period of eight calendar months, 36 CVD patients aged 44–77 were
recruited to participate in a field experiment. A total of 1,059 valid days of activity data gener-
ated by 13 participants finishing the study were analysed in detail. Results provide the first
complete activity profile of CVD patients on different intensity levels over a longer period of
time. Weekly results were provided as an average according to number of steps, kcals burned,
total activity time, sedentary behaviour and physical activity of light, moderate and vigorous
intensity. Analysis of mean development of activity throughout the entire observation period
supports previous research into the importance of attending rehabilitation programmes for
CVD patients. They increased their weekly step-counts by almost a third throughout the study
and showed an almost 10% higher energy expenditure compared to the beginning of their
rehabilitation. The total activity time improved by more than 7 hours per week and sedentary
behaviour was reduced by more than 6 hours each. The mean physical activity of light intensity
showed an improvement of more than 20% from about 34 h to almost 40 h per week. MVPA
increased by about 18% or 80 minutes. Results show varying characteristics of some activities
throughout the study, especially differences between the first (weeks 1–6) and second (weeks
7–12) time period of the study. Although intensive care and supervision only took place in the
first period, which was equivalent to the time period of the routine phase II cardiac rehabilita-
tion programme, steps, total activity time, physical activities of light intensity as well as MVPA
partly increased in the period following the completion of the rehabilitation programme. Fur-
ther, sedentary behaviour, which remained almost constant in the first 6 weeks, was reduced
by more than 4 h per week in subsequent weeks (weeks 7–12). A possible explanation for this
might be that participants more or less reduced heart controlled physical exercise sessions per
week in the second period and may have tried to compensate for the lack of training with a
higher level of overall physical activities of lower intensity. Further, an increase of total activity
time is usually accompanied with shorter periods of sitting (improvement of sedentary behav-
iour). In addition, weekly activity data shows changes in the middle of both periods and in the
weeks following examinations. This may depend on examination results combined with medi-
cal consultation by a physician.
However, activity profiles based on objectively generated data were only created for the par-
ticipants of the study group wearing an activity tracker. To compare development of perfor-
mance between this group and the control group consisting of participants without any digital
records, we considered examination data at three different intervals: at the beginning (t1), 6
weeks later at the end of phase II rehabilitation programme (t2), and at the very end of the
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12-week study (t3). The focus was for the most part on physical performance data generated
during cardiac stress tests including ECG and lactate measurement. Results show significant
differences between the study group and control group in development of two indicators for
comparing improvement or deterioration of the cardiovascular system: maximum power
achieved by participants during a cardiac stress test in W and the calculated relative perfor-
mance as a percentage representing the actual performance in relation to the target perfor-
mance. Between t1 and t2, the development was similar for both groups. Afterwards, however,
between t2 and t3, results show significant differences between the groups. Although develop-
ment was not as noticeable as in the first period, the study group, at least, further improved
maximum power by 3.61% and relative performance by 7.24% until t3. In contrast, maximum
power achieved by the control group deteriorated during the same period by 9.17% and rela-
tive performance deteriorated by 9.64%. These results are astonishing as they show that maxi-
mum power achieved by participants of the control group and relative performance of this
group are just slightly above baseline levels during the examination at the end of the study (t3)
and show a significant decline in health outcomes and performance of the cardiovascular sys-
tem compared to the examination at the end of the routine rehabilitation programme (t2).
Importantly, study group participants not only maintained the same performance level as
at t2, they improved performance even further during the six weeks that followed. This result
may be explained in several ways. One might be the fact that during the rehabilitation pro-
gramme (equivalent to the first six weeks of the study) participants of both groups received
intensive medical counselling, performed physical exercises under supervision and attended
mandatory lectures and seminars. Afterwards, in the six weeks following t2, control group par-
ticipants did not receive any further feedback, which may have decreased personal motivation
for physical activity once they no longer received assistance from a medical team. Yet in the
study group, activity trackers still provided information about daily activity and activities with
different intensity levels. They provided motivating feedback, thereby encouraging partici-
pants to remain motivated or to further improve activity and sedentary behaviour leading
towards a healthier lifestyle.
Even if we consider the total observation period of 12 weeks, during which both groups at
least improved overall performance, we still have significant differences between the groups in
development of performance. Specifically, the study group showed a more than 10% higher
overall improvement of maximum power than the control group and an almost 15% higher
overall improvement of relative performance. A combination of activities and diet that are
supported by the tracking device and the web service for monitoring as well as feedback of the
monitoring architecture has positively affected the study groups’ lifestyle. Thus, the results of
the field experiment are encouraging, and provide support for the fact that smart wearables
have the potential to improve the health status of patients.
Limitations
The fact that no activity data was generated or recorded by the control group was part of the
study design. Thus, the setup used in this field experiment was to compare groups by perfor-
mance parameters. Therefore, physical activity or intensity levels were compared by indicators
permitting conclusions to be drawn about physical activities. The sample size of both groups is
comparable to other studies on activity trials over a period of 12 weeks (see, for example,
[30,74]. Yet, we make a call for replication studies to further substantiate, or eventually revise,
the findings of the present study. Longer periods of monitoring may provide an additional
insight into development of activities or improvement of performance parameters. Further,
results may not be generalizable for patients with CVD who do not undergo cardiac
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rehabilitation. In addition, results are only representative for patients undergoing cardiac reha-
bilitation at an outpatient rehabilitation centre and hence are not in a stationary rehabilitation
setting. Further, caution must be exercised, as the findings of the field experiment might not
be transferable to all cardiac patients because of the variety of possible disease symptoms, pat-
terns and medical histories. Personal anamneses (e.g., blood pressure, diabetes or smoking sta-
tus) were not particularly considered during the recruiting process.
Concluding comment
The activity data generated by participants within the field experiment provides novel insights
into patients’ activity, exercise and sedentary behaviour. Nearly round-the-clock monitoring
was performed over a total time period of 19 weeks and an individual observation period of 12
weeks per cardiac patient. Immediate and informative feedback provided by activity trackers
obviously increases self-efficacy for physical activity in CVD patients. Our results provide evi-
dence for potentially positive effects of digital self-tracking for monitoring LTPA by CVD
patients undergoing cardiac rehabilitation on performance of the cardiovascular system and
improvement of physical activities.
Overall, our results are consistent with findings in the scientific literature in which authors
underline the great potential of smart wearables in the management of chronic diseases and
predict a promising future for them enhancing recovery in rehabilitation (e.g., [16,18,21,29]).
This also has an impact on the design of self-management approaches in the rehabilitation set-
ting. Hence, the use of smart wearables can prolong the success of the rehabilitation outside of
the organized rehabilitation setting.
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